Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 8—August 2009
Research

Dengue 1 Virus and Dengue Hemorrhagic Fever, French Polynesia, 2001

Bruno HubertComments to Author  and Scott B. Halstead
Author affiliations: Directorate of Health, Papeete, Tahiti, French Polynesia (B. Hubert); Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA (S.B. Halstead)

Main Article

Table

History of outbreaks with dengue viruses with documented serotype in French Polynesia*

Year Dengue virus serotype
1944 1
1964–1965 3
1969 3
1971 2
1975–1976 1
1979 4
1988–1989 1
1989–1990 3
1996–1997 2
2001 1

*Source: (4).

Main Article

References
  1. Guzman  MG, Kouri  GP, Bravo  J, Soler  M, Vazquez  S, Morier  L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg. 1990;42:179–84 .PubMedGoogle Scholar
  2. Guzman  MG, Kouri  G, Valdes  L, Bravo  J, Alvarez  M, Vazques  S, Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol. 2000;152:793–9 and. DOIPubMedGoogle Scholar
  3. Rodriguez-Roche  R, Alvarez  M, Holmes  EC, Bernardo  L, Kouri  G, Gould  EA, Dengue virus type 3, Cuba, 2000–2002. Emerg Infect Dis. 2005;11:773–4 . DOIPubMedGoogle Scholar
  4. Chungue  E, Deparis  X, Murgue  B. Dengue in French Polynesia: major features, surveillance, molecular epidemiology and current situation. Pac Health Dialog. 1998;5:154–62.
  5. Hubert  B. Type 1 dengue fever epidemic in French Polynesia—2001 [monograph on the Internet] [cited 2009 Feb 20]. Available from http://www.spc.int/phs/PPHSN/Outbreak/reports/Dengue_report2001-FrenchPolynesia.pdf
  6. World Health Organization. Dengue haemorrhagic fever. Diagnosis, treatment, prevention and control. Geneva: The Organization; 1997.
  7. Chungue  E, Boutin  JP, Roux  J. Significance of IgM titration by an immunoenzyme technique for the serodiagnosis and epidemiological surveillance of dengue in French Polynesia [in French]. Res Virol. 1989;140:229–40 and. DOIPubMedGoogle Scholar
  8. Laille  M, Roche  C. Comparison of dengue-1 virus envelope glycoprotein gene sequences from French Polynesia. Am J Trop Med Hyg. 2004;71:478–84 .PubMedGoogle Scholar
  9. Halstead  SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res. 2003;60:421–67 and. DOIPubMedGoogle Scholar
  10. Halstead  SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239:476–81 and. DOIPubMedGoogle Scholar
  11. Vaughn  DW. Invited commentary: dengue lessons from Cuba. Am J Epidemiol. 2000;152:800–3 and. DOIPubMedGoogle Scholar
  12. Gubler  DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480–96 .PubMedGoogle Scholar
  13. Rico-Hesse  R, Harrison  LM, Salas  RA, Tovar  D, Nisalak  A, Ramos  C, Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 1997;230:244–51 and. DOIPubMedGoogle Scholar
  14. Nimmannitya  S, Halstead  SB, Cohen  SN, Margiotta  MR. Dengue and chikungunya virus infection in man in Thailand, 1962–1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg. 1969;18:954–71 .PubMedGoogle Scholar
  15. Halstead  SB, Lan  NT, Myint  TT, Shwe  TN, Nisalak  A, Kalyanarooj  S, Dengue hemorrhagic fever in infants: research opportunities ignored. Emerg Infect Dis. 2002;8:1474–9 . DOIPubMedGoogle Scholar
  16. Kliks  SC, Nimmanitya  S, Nisalak  A, Burke  DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411–9 .PubMedGoogle Scholar
  17. Watanaveeradej  V, Endy  TP, Samakoses  R, Kerdpanich  A, Simasathien  S, Polprasert  N, Transplacentally transferred maternal–infant antibodies to dengue virus. Am J Trop Med Hyg. 2003;69:123–8 .PubMedGoogle Scholar
  18. Chau  TN, Quyen  NT, Thuy  TT, Tuan  NM, Hoang  DM, Dung  NT, Dengue in Vietnamese infants–results of infection-enhancement assays correlate with age-related disease epidemiology, and cellular immune responses correlate with disease severity. J Infect Dis. 2008;198:516–24 and. DOIPubMedGoogle Scholar
  19. Simmons  CP, Chau  TN, Thuy  TT, Tuan  NM, Hoang  DM, Thien  NT, Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis. 2007;196:416–24 and. DOIPubMedGoogle Scholar
  20. Siegrist  CA. Neonatal and early life vaccinology. Vaccine. 2001;19:3331–46 and. DOIPubMedGoogle Scholar
  21. Guzman  MG, Kouri  G, Bravo  J, Valdes  L, Vazquez  S, Halstead  SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118–24 and. DOIPubMedGoogle Scholar
  22. Gamble  J, Bethell  D, Day  NP, Loc  PP, Phu  NH, Gartside  IB, Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond). 2000;98:211–6 and. DOIPubMedGoogle Scholar
  23. Bethell  DB, Gamble  J, Pham  PL, Nguyen  MD, Tran  TH, Ha  TH, Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis. 2001;32:243–53 and. DOIPubMedGoogle Scholar
  24. Imrie  A, Zhao  Z, Bennett  SN, Kitsutani  P, Laille  M, Effler  P. Molecular epidemiology of dengue in the Pacific: introduction of two distinct strains of the dengue type-1 virus into Hawaii. Ann Trop Med Parasitol. 2006;100:327–36 and. DOIPubMedGoogle Scholar
  25. Caceres  C, Yung  V, Araya  P, Tognarelli  J, Villagra  E, Vera  L, Complete nucleotide sequence analysis of a dengue-1 virus isolated on Easter Island, Chile. Arch Virol. 2008;153:1967–70 and. DOIPubMedGoogle Scholar
  26. Perret  C, Abarca  K, Ovalle  J, Ferrer  P, Godoy  P, Olea  A, Dengue-1 virus isolation during first dengue fever outbreak on Easter Island, Chile. Emerg Infect Dis. 2003;9:1465–7 . DOIPubMedGoogle Scholar
  27. Effler  PV, Pang  L, Kitsutani  P, Vorndam  V, Nakata  M, Ayers  T, Dengue fever, Hawaii, 2001–2002. Emerg Infect Dis. 2005;11:742–9 . DOIPubMedGoogle Scholar
  28. Sangkawibha  N, Rojanasuphot  S, Ahandrik  S, Viriyapongse  S, Jatanasen  S, Salitul  V, Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984;120:653–69 .PubMedGoogle Scholar
  29. Vaughn  DW, Green  S, Kalayanarooj  S, Innis  BL, Nimmannitya  S, Suntayakorn  S, Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2–9 and. DOIPubMedGoogle Scholar
  30. Gibbons  RV, Kalanarooj  S, Jarman  R, Nisalak  A, Vaughn  DW, Endy  TP, Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg. 2007;77:910–3 .PubMedGoogle Scholar

Main Article

Page created: January 08, 2016
Page updated: January 08, 2016
Page reviewed: January 08, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external